What the FDA labels say about taking them together
Dexrazoxane and epirubicin
Epirubicin's FDA label of July 24, 2026 names dexrazoxane in its warnings and precautions section; the dexrazoxane label PlainMeds reads does not name epirubicin.
Check it at the source: the dexrazoxane FDA label on DailyMed (effective June 23, 2025, Gland Pharma Limited); the epirubicin FDA label on DailyMed (effective July 24, 2026, Pharmacia & Upjohn Company LLC).
What does the dexrazoxane label say about epirubicin?
Dexrazoxane's label (effective June 23, 2025) does not name epirubicin in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Dexrazoxane), Gland Pharma Limited, effective June 23, 2025 (SPL set c9c625fc-8852-4ed4-bcf2-63f46a706782), via openFDA; the full label on DailyMed
What does the epirubicin label say about dexrazoxane?
Epirubicin label, warnings and precautionsIf appropriate, administer dexrazoxane at the site of extravasation as soon as possible and within the first 6 hours after extravasation.
Source: FDA drug label (Ellence), NDA050778 (Pfizer Inc), as published by Pharmacia & Upjohn Company LLC, effective July 24, 2026 (SPL set 0a03c798-a652-4895-b29c-3b521a89ba42), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Dexrazoxane | Epirubicin | |
|---|---|---|
| Labeled for | n/a | n/a |
| Boxed warning | No | Yes |
| Pharmacy cost (NADAC) | n/a | n/a |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once